secwatch / observer
8-K filed May 29, 2026, 9:26 AM ET ticker MBRX CIK 0001659617
other material confidence high sentiment positive materiality 0.75

Moleculin ASCO data: Annamycin shows no cardiotoxicity at high cumulative doses

Moleculin Biotech, Inc.

item 7.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001437749-26-018819
form_type
8-K
ticker
MBRX
cik
0001659617
company_name
Moleculin Biotech, Inc.
filed_at
2026-05-29T13:26:14+00:00
discovered_at
2026-05-29T13:27:00.310459+00:00
generated_at
2026-05-29T13:27:23.070826+00:00
sec_items
["7.01", "9.01"]
event_type
other_material
sentiment
positive
materiality_score
0.75
calibrated_materiality_score
0.75
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001437749-26-018819
json_url
https://secwatch.observer/filing/0001437749-26-018819.json
markdown_url
https://secwatch.observer/filing/0001437749-26-018819.md
text_url
https://secwatch.observer/filing/0001437749-26-018819.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1659617/000143774926018819/0001437749-26-018819-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1659617/000143774926018819/mbrx20260529_8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Comparable filings

MDAI

Spectral AI gets FDA clearance for DeepView burn indication; targets first commercial sales by year-end 2026

Spectral AI, Inc. June 1, 2026, 4:01 PM ET other_material Items 5.07, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

DBX

Dropbox secures $400M revolving credit facility, authorizes $900M share repurchase program

DROPBOX, INC. June 1, 2026, 9:06 AM ET other_material Items 1.01, 2.03, 7.01, 8.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

LIXT

Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board

LIXTE BIOTECHNOLOGY HOLDINGS, INC. June 1, 2026, 8:55 AM ET other_material Items 5.02, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

BMNR

Bitmine holds 5.42M ETH (4.49% of supply); total crypto + cash = $11.6B

BITMINE IMMERSION TECHNOLOGIES, INC. June 1, 2026, 8:45 AM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

TTRX

Turn Therapeutics GX-03 Phase 2 interim: 92.6% EASI-50 at 4 weeks; no SAEs

Turn Therapeutics Inc. June 1, 2026, 8:45 AM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

AIRJ

AirJoule Technologies raises $15M in registered direct offering at $4.10/share

AirJoule Technologies Corp. June 1, 2026, 8:34 AM ET other_material Items 1.01, 5.07, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

NXTC

NextCure Phase 1 SIM0505 data: 55% ORR in gynecologic cancers; cash into Q1 2027

NextCure, Inc. June 1, 2026, 8:10 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

JSPR

Jasper Therapeutics initiates strategic review including potential sale or wind-down

Jasper Therapeutics, Inc. June 1, 2026, 8:01 AM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0001437749-26-018819
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.